Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $37.2800 (3.99%) ($35.1800 - $37.6400) on Fri. Nov. 16, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.74% (three month average) | RSI | 66 | Latest Price | $37.2800(3.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(51%) IBB(50%) IWO(50%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -1.87% in a week (0% probabilities). VXX(-14%) TLT(-14%) VIXM(-13%) UUP(-12%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.87% (StdDev 3.74%) | Hourly BBV | 0 () | Intraday Trend | 5.3% | | | |
|
5 Day Moving Average | $35.1(6.21%) | 10 Day Moving Average | $36.03(3.47%) | 20 Day Moving Average | $35.19(5.94%) | To recent high | -14.3% | To recent low | 17.9% | Market Cap | $2.77b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |